S1P Receptor Modulator Drugs Market - Top Companies and Manufacturers

Companies Dominating the S1P Receptor Modulator Drugs Landscape

Novartis International AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Bristol Myers Squibb Company
Johnson & Johnson
Biogen Inc.
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Quality Pharma Products Pvt. Ltd.
Pfizer Inc.
Sanofi S.A.
Medicinum Healthcare Pvt. Ltd.

Browse Key Market Insights with Data Illustration:

S1P Receptor Modulator Drugs Market Size & Share | Global Forecast Report 2024-2036

In the News

Bristol Myers Squibb announced a definitive agreement to acquire Mirati Therapeutics, a commercial-stage targeted oncology company specializing in KRAS G12C inhibitors. This USD 4.8 billion acquisition adds the FDA-approved KRAZATI® (adagrasib) to BMS's portfolio, along with promising early-stage assets targeting KRAS and other driver mutations.
BMS and Seagen announced a collaboration to launch a Phase 3 trial evaluating ADCETRIS® in combination with chemotherapy for treatment-naive adult patients with Hodgkin lymphoma. This partnership leverages the strengths of both companies to pursue potentially curative options for this cancer.

Frequently Asked Questions (FAQ)

Expanding applications in autoimmune diseases, rising investment in research and development (R&D), and expanding geographical presence and market access are the major factors driving the growth of the S1P receptor modulator drugs market.

The market size of S1P receptor modulator drugs is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market are Novartis International AG, Bristol Myers Squibb Company, Johnson & Johnson, Biogen Inc., Merck & Co., Inc., F. Hoffmann-La Roche Ltd, and others.

The ozanimod segment is anticipated to garner the largest market size of 61% by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share of 41% by the end of 2036 and provide more business opportunities in the future.

S1P Receptor Modulator Drugs Market - Top Companies and Manufacturers

Companies Dominating the S1P Receptor Modulator Drugs Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the major factor driving the growth of the S1P receptor modulator drugs market?

What would be the CAGR of the S1P receptor modulator drugs market over the forecast period?

Who are the major players dominating the S1P receptor modulator drugs market?

Which segment captures the largest market size in the type segment in the S1P receptor modulator drugs market?

Which region will provide more business opportunities for the growth of the S1P receptor modulator drugs market in the future?